Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas.
Bodei L, Handkiewicz-Junak D, Grana C, Mazzetta C, Rocca P, Bartolomei M, Lopera Sierra M, Cremonesi M, Chinol M, Mäcke HR, Paganelli G.
Bodei L, et al. Among authors: mazzetta c.
Cancer Biother Radiopharm. 2004 Feb;19(1):65-71. doi: 10.1089/108497804773391694.
Cancer Biother Radiopharm. 2004.
PMID: 15068613